Paid Clinical Trials in Dearborn, MI
As of September 2026, 72 paid clinical trials are recruiting in Dearborn, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Dearborn offers studies at sites including Henry Ford Medical Center-Fairlane for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Hypertension, Advanced Esophageal Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Dearborn
Trials by drug in Dearborn
Filter results
Newly added in Dearborn
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
69 clinical trials
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
SuperSaturated Oxygen Comprehensive Observational Registry
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Top Research Study Locations in Dearborn
Researchers run research studies in Dearborn, MI at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Henry Ford Medical Center-Fairlane | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Breast Cancer | 33 |
| Corewell Health Dearborn Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8 | 16 |
| Revival Research Institute, LLC | Atherosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD), COVID-19 SARS-CoV-2 Infection | 6 |
| Revival Research Institute, LLC - Dearborn | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 2 |
| Metro Detroit Endocrinology Center | Graves Disease, Graves' Disease, Hypothyroidism | 2 |
| AMR Dearborn | Heart Failure | 1 |
| Advanced Surgery Center | Lumbar Spinal Stenosis | 1 |
| Aurinia Investigational Site | Myasthenia Gravis, Generalized | 1 |
| Center for Neurolgoical Studies (CNS) | Anterior Pituitary Hyposecretion Syndrome, Concussion, Brain, Growth Hormone Deficiency | 1 |
| Corazon Imaging | Atherosclerosis, Cardiovascular Inflammation, Coronary Artery Disease | 1 |
| Dearborn Cardiology | Chronic Total Occlusion of Artery of the Extremities | 1 |
| Dearborn Surgery Center | Lumbar Spinal Stenosis | 1 |
| Executive Ambulatory Surgical Center | Lumbar Spinal Stenosis | 1 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive | 1 |
| Henry Ford Health System - Dearborn | Lumbar Spinal Stenosis | 1 |
| Henry Ford Medical Center - Fairlane Emergency Department | Hypertension, Severe Hypertension | 1 |
| Michigan Hematology & Oncology Consultants - Dearborn | Plasma Cell Myeloma Refractory | 1 |
| Michigan Hematology & Oncology Consultants - MedOnc Dearborn | Colorectal Cancer, Melanoma, Non-small Cell Lung Cancer | 1 |
| Michigan Hematology and Oncology Consultants | Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer | 1 |
| Verexa Health | Rhinovirus Infection | 1 |
| WSUPG Dermatology | Hidradenitis Suppurativa | 1 |
Active & Upcoming Studies in Dearborn (2026)
Recruiting trials in Dearborn grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (45 active studies)
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
- Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial · Phase 3 · Alliance for Clinical Trials in Oncology
Cardiovascular (7 active studies)
- Emergency Department-Initiated Team-Based Care for Severe Hypertension · Henry Ford Health System
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
Diabetes & metabolic (3 active studies)
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
Mental health & behavior (2 active studies)
- A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse · Phase 2 · Eli Lilly and Company
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Vaccines (1 active study)
Common conditions studied in Dearborn
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (3 active studies)
- Hypertension (3 active studies)
- Advanced Esophageal Adenocarcinoma (2 active studies)
- Advanced Gastric Adenocarcinoma (2 active studies)
- Advanced Gastroesophageal Junction Adenocarcinoma (2 active studies)
Leading research sponsors in Dearborn
- National Cancer Institute (NCI)
- NRG Oncology
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Boehringer Ingelheim
Frequently asked questions
How many paid clinical trials are currently recruiting in Dearborn?
There are approximately 72 recruiting clinical trials in Dearborn, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Dearborn pay participants?
Most recruiting trials in Dearborn compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Dearborn?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Dearborn?
The most common conditions under active study in Dearborn include Anatomic Stage II Breast Cancer AJCC v8 (5), Anatomic Stage IIIA Breast Cancer AJCC v8 (3), Hypertension (3), Advanced Esophageal Adenocarcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Dearborn?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Dearborn on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Dearborn?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Dearborn?
Recruiting research sites in Dearborn include Henry Ford Medical Center-Fairlane, Corewell Health Dearborn Hospital, Revival Research Institute, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Dearborn right now?
The largest active categories in Dearborn are Cancer & tumors (45), Cardiovascular (7), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.